Patent 7994360 was granted and assigned to XTL Biopharmaceuticals on August, 2011 by the United States Patent and Trademark Office.
The present invention relates to benzofuran derivatives for use in antiviral compositions. More specifically, the present invention relates to compositions and methods for the treatment of hepatitis C virus by administering the benzofuran derivatives in a therapeutically effective amount.